Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 10-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,877 | -7,392 | N/A | N/A | 3,763 |
| Depreciation Amortization | 20 | 18 | N/A | N/A | 4,731 |
| Accounts payable and accrued liabilities | 154 | 71 | N/A | N/A | N/A |
| Other Working Capital | -426 | 84 | N/A | N/A | -3,258 |
| Other Operating Activity | 576 | 6,502 | 0 | 0 | -1,060 |
| Operating Cash Flow | $-3,554 | $-716 | $N/A | $N/A | $4,176 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | N/A | N/A | N/A | -17,813 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3,159 |
| Investing Cash Flow | $-20 | $N/A | $N/A | $N/A | $-20,972 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 300 | N/A | N/A | N/A |
| Common Stock Issued | 10,295 | 977 | N/A | N/A | N/A |
| Other Financing Activity | -35 | -116 | 0 | 0 | 17,655 |
| Financing Cash Flow | $10,260 | $1,161 | $N/A | $N/A | $17,655 |
| Beginning Cash Position | 555 | 111 | N/A | N/A | 2,025 |
| End Cash Position | 7,241 | 555 | N/A | N/A | 2,884 |
| Net Cash Flow | $6,686 | $445 | $N/A | $N/A | $859 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,554 | -716 | N/A | N/A | 4,176 |
| Capital Expenditure | -20 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -3,574 | -716 | 0 | 0 | 4,176 |